BrainStorm Cell Therapeutics
BCLI
#9833
Rank
A$1.83 M
Marketcap
$0.35
Share price
3.51%
Change (1 day)
11.02%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Cash on Hand

Cash on Hand as of June 2024 : A$5.2 M

According to BrainStorm Cell Therapeutics's latest financial reports the company has A$5.2 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BrainStorm Cell Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$4.38 M-85.57%
2021-12-31A$30.38 M-44.17%
2020-12-31A$54.42 M6623.51%
2019-12-31A$0.8 M-91.92%
2018-12-31A$10.02 M0.9%
2017-12-31A$9.93 M-28.32%
2016-12-31A$13.85 M-36.73%
2015-12-31A$21.9 M110.3%
2014-12-31A$10.41 M165.21%
2013-12-31A$3.92 M-0.34%
2012-12-31A$3.94 M110.13%
2011-12-31A$1.87 M1941.7%
2010-12-31A$0.09 M8115.54%
2009-12-31A$0 M-61.39%
2008-12-31A$0 M-97.06%
2007-12-31A$0.09 M29.31%
2006-12-31A$0.07 M
2006-03-31A$0.41 M-39.65%
2005-03-31A$0.68 M11050.5%
2004-03-31A$0 M-63.12%
2003-03-31A$0.01 M-75.54%
2002-03-31A$0.06 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$4.15 B 79,807.75%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.58 B 30,363.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.85 B 35,558.40%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.86 B 54,927.39%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.14 B 2,601.73%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA